Reveal HealthTech Secures $7.2M to Enhance AI in US Healthcare

Reveal HealthTech, a two-year-old startup, has successfully raised $7.2 million in a Series A funding round led by Leo Capital, with participation from Sanos Capital. This funding marks a significant step for the company as it seeks to deepen the integration of artificial intelligence in the US healthcare sector.

The Vision Behind Reveal HealthTech

Founded by Sanchit Mullick and Dr. Salim Ashar, Reveal HealthTech emerged from the growing digitization in US healthcare. With over 20 years of electronic health record implementations, the sector has amassed a wealth of digital data. Mullick, who has an extensive background in technology services, saw an opportunity to leverage this data.

Rather than replacing doctors, Reveal HealthTech aims to reimagine workflows. According to Mullick, “AI in healthcare is often equated with clinical decision support. But that’s just a sliver of the opportunity. We are using AI to amplify and streamline clinical workflows, whether it’s predicting device adherence, tracking cancer screenings, or improving home-based care scheduling.”

Focus on Workflow Optimization

One of Reveal’s notable projects involved a US medical device maker. Reveal developed a model to predict patient adherence to prescribed devices, resulting in a 10–15% improvement. This not only boosted revenue but also improved outcomes for patients managing chronic diseases.

Reveal HealthTech’s flagship platforms include:

• BioCanvas: Integrates multimodal data to accelerate clinical trial recruitment and oncology research.
• Prism AI: Helps build intelligent workflow automation agents.

These platforms are designed to support healthcare providers in optimizing their operations and improving patient care.

Scaling with New Funding

The recent funding round is pivotal for Reveal’s growth. Mullick stated, “So far, our go-to-market motion has been very founder-led. With this round, we want to build a stronger commercial engine while doubling down on platforms like BioCanvas that can be taken to scale.”

The company, which has 120 employees across the US and India, plans to enhance its commercial capabilities and expand its product offerings. Leadership includes alumni from SpaceX, NASA, and Athenahealth, underscoring the company’s strong technical foundation.

The Bigger Picture: AI in Healthcare

Investors like Dr. Pankaj Jethwani of W Health Ventures see a timely opportunity in Reveal’s approach. “Healthcare cannot be solved with one-size-fits-all point solutions. We see an incredible opportunity for Reveal to support the rapid AI adoption within the US healthcare industry.”

As AI continues to evolve, its role in healthcare becomes more critical. Companies like Reveal HealthTech are at the forefront, crafting tailored solutions that demonstrate measurable business impact. According to Leo Capital partner Rajul Garg, Reveal’s strength lies in its ability to deliver solutions with time-bound results.

The Road Ahead

Reveal HealthTech is not just about technology; it’s about transforming healthcare delivery. By joining the Cipher Collective, a network of AI-driven healthtech firms, Reveal is poised to collaborate on care delivery transformation.

The company’s journey reflects a broader trend in healthcare: the integration of AI to enhance efficiency and patient outcomes. As the healthcare landscape evolves, the question remains: How will AI redefine the future of patient care?

For more information about Reveal HealthTech and its innovative solutions, visit their website.

For similar articles visit TechScoopIndia